title: Systemic and topical protection studies using Pseudomonas aeruginosa flagella in an ocular model of infection.
abstract: Purified flagella from P. aeruginosa ATCC 19660 were used for active, passive, or topical immunization prior to corneal challenge with strain 19660. At 30 days post-infection, a significant number of mice actively or passively immunized with flagella and infected with the homologous bacterial strain were protected from ocular disease when compared to control animals. In topical immunization studies, premixing of 19660 flagella with the bacterial inoculum prior to ocular challenge with strain 19660, provided results similar to those of the active or passive immunization studies. A reduced lipopolysaccharide (LPS:1 E.U./mg) flagella preparation was also produced and used similarly. Again, significant protection was achieved in mice immunized by flagella regardless of the immunization route. An in vitro adherence assay also was performed to examine quantitatively the effect of exogenously applied flagella, or an antiflagella monoclonal antibody (MAb) on bacterial adhesion. Premixing of the bacterial inoculum with flagella or the MAb prior to applying it topically to corneas in organ culture all significantly inhibited bacterial binding. These results strongly suggest that significant ocular protection is achieved with either active or passive immunization, or premixing of the bacterial inoculum with flagella from strain 19660 prior to ocular challenge with the homologous bacterial strain. They also indicate that topical application of flagella or antiflagella MAb provide protection against ocular disease by decreasing bacterial adhesion to cornea.
authors.affiliation: Department of Anatomy/Cell Biology, Wayne State University, School of Medicine, Detroit, MI 48201.
authors.forename: X L
authors.initials: XL
authors.lastname: Rudner
authors.forename: L D
authors.initials: LD
authors.lastname: Hazlett
authors.forename: R S
authors.initials: RS
authors.lastname: Berk
mesh_terms: D000818:Animals; D000911:Antibodies, Monoclonal; D001422:Bacterial Adhesion / Q000276:immunology; D015169:Colony Count, Microbial; D003316:Corneal Diseases / Q000382:microbiology / Q000517:prevention & control*; D004195:Disease Models, Animal; D004591:Electrophoresis, Polyacrylamide Gel; D015818:Eye Infections, Bacterial / Q000517:prevention & control*; D005260:Female; D005407:Flagella / Q000276:immunology* / Q000648:ultrastructure; D007116:Immunization, Passive; D008070:Lipopolysaccharides; D051379:Mice; D008807:Mice, Inbred BALB C; D008810:Mice, Inbred C57BL; D009924:Organ Culture Techniques; D011552:Pseudomonas Infections / Q000517:prevention & control*; D011550:Pseudomonas aeruginosa / Q000254:growth & development / Q000276:immunology*; D014611:Vaccination
chemical_list: D000911:Antibodies, Monoclonal; D008070:Lipopolysaccharides